PARSABIV 2.5 mg, solution for injection bottle, 0.5 ml
Active ingredients: Etelcalcetide hydrochloride, Etelcalcetide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 0.5 mlintraveineuse;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PARSABIV 2,5 mg, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;voie extracorporelle autre
- Presentation description
- 1 flacon(s) en verre de 0,5 ml
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Jun 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69279221CIP73007874CIP133400930078747Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'ÉTELCALCÉTIDEsolution | — | SA |
| ÉTELCALCÉTIDEsolution | 2,5 mg · un flacon de 0,5 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.